Plus: The IMF lifts its growth forecast for China on the back of stronger data. And, drugmaker Merck closes in on a $1.3 billion deal to buy Eyebiotech. Peter Granitz hosts.\xa0\n\n\n\nSign up for the WSJ's free What's News newsletter.\n\nLearn more about your ad choices. Visit megaphone.fm/adchoices